Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biobucks
Biotech
Merck KGaA signs $1.4B biobuck ADC deal with Caris
Merck KGaA has become the latest biopharma to swell its oncology pipeline with further antibody-drug conjugate potential this week.
James Waldron
Apr 4, 2024 8:25am
Ferrer offers $122M biobucks for ex-US license to Verge ALS drug
Mar 25, 2024 8:16am
Merck KGaA paying $16M to join C4's protein degrader hunt
Mar 4, 2024 10:18am
BMS signs $674M biobucks pact with VantAI for molecular glues
Feb 13, 2024 11:00am
Biopharma won’t stop betting big on M&A earnouts as payouts slow
Oct 17, 2023 6:00am
Genentech signs off on $1B biobucks to expand PeptiDream collab
Sep 20, 2023 7:14am